↓ Skip to main content

MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy

Overview of attention for article published in Journal of Translational Medicine, December 2012
Altmetric Badge

Citations

dimensions_citation
73 Dimensions

Readers on

mendeley
79 Mendeley